Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASCENDIS PHARMA A/S

(ASND)
  Report
Delayed Nasdaq  -  04:00 2022-12-01 pm EST
121.75 USD   -1.06%
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/22Ascendis Pharma to Participate in the 5th Annual Evercore ISI HealthCONx Conference
AQ
11/16European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Slightly Higher in Thursday Trading

09/08/2022 | 11:01am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -6.91% 2.02 Delayed Quote.-46.13%
AKARI THERAPEUTICS, PLC -4.09% 0.53 Delayed Quote.-64.67%
AMARIN CORPORATION PLC 3.48% 1.19 Delayed Quote.-64.69%
ARGENX SE -1.71% 380.4 Real-time Quote.22.74%
ASCENDIS PHARMA A/S -1.06% 121.75 Delayed Quote.-9.50%
AUTOLUS THERAPEUTICS PLC 8.33% 2.86 Delayed Quote.-44.89%
CELLECTIS S.A. 0.74% 2.176 Real-time Quote.-70.97%
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.89% 30.62 Delayed Quote.-46.92%
FRESENIUS SE & CO. KGAA 0.72% 26.7 Delayed Quote.-25.11%
GSK PLC -0.96% 1402 Delayed Quote.-13.88%
MEREO BIOPHARMA GROUP PLC 0.33% 0.7907 Delayed Quote.-50.58%
SMITH & NEPHEW PLC 0.32% 1082.5 Delayed Quote.-16.62%
SPARK NETWORKS SE 6.03% 1.23 Delayed Quote.-60.83%
TELEFÓNICA, S.A. -1.68% 3.575 Delayed Quote.-5.56%
VODAFONE GROUP PLC -0.09% 91.48 Delayed Quote.-18.48%
VOXELJET AG 1.52% 2.68 Delayed Quote.-55.25%
ZEALAND PHARMA A/S 0.20% 203.4 Delayed Quote.39.90%
All news about ASCENDIS PHARMA A/S
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/22Ascendis Pharma to Participate in the 5th Annual Evercore ISI HealthCONx Conference
AQ
11/16European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
MT
11/15Morgan Stanley Adjusts Price Target on Ascendis Pharma to $148 From $146, Maintains Ove..
MT
11/15Ascendis Pharma Submits Marketing Authorisation Application to the European Medicines A..
AQ
11/14European ADRs Continue to Trend Higher in Monday Trading
MT
11/14Ascendis Pharma Submits Marketing Authorization Application in EU for Hypoparathyroidis..
MT
11/14Dose Escalation Data from transcendIT-101 Ascendis Pharma's Phase 1/2 Trial of TransCon..
AQ
11/14Once-Weekly TransCon CNP Achieved Primary Efficacy Objective, with Superiority at 100 -..
AQ
11/14Transcript : Ascendis Pharma A/S - Special Call
CI
More news
Analyst Recommendations on ASCENDIS PHARMA A/S
More recommendations
Financials
Sales 2022 47,4 M 48,9 M 48,9 M
Net income 2022 -528 M -544 M -544 M
Net cash 2022 513 M 530 M 530 M
P/E ratio 2022 -12,5x
Yield 2022 -
Capitalization 6 668 M 6 876 M 6 876 M
EV / Sales 2022 130x
EV / Sales 2023 44,0x
Nbr of Employees 639
Free-Float 10,3%
Chart ASCENDIS PHARMA A/S
Duration : Period :
Ascendis Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASCENDIS PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 119,33 €
Average target price 154,17 €
Spread / Average Target 29,2%
EPS Revisions
Managers and Directors
Jan M°ller Mikkelsen President, CEO & Executive Director
Scott Thomas Smith Chief Financial Officer & Senior Vice President
Albert Cha Chairman
Birgitte Volck SVP, Head-Clinical Development & Medical Affairs
Kennett Sprog°e Senior Vice President, Head-Innovation & Research
Sector and Competitors
1st jan.Capi. (M$)
ASCENDIS PHARMA A/S-9.50%6 876
VERTEX PHARMACEUTICALS46.07%81 217
REGENERON PHARMACEUTICALS, INC.19.03%80 283
BIONTECH SE-34.26%40 589
WUXI APPTEC CO., LTD.-34.22%32 137
GENMAB A/S25.29%29 594